Zak Kohane: expect far more LLM use in rare cancer evaluation and treatment
zakkohane · x · 2026-10-17
Zak Kohane highlights a NEJM AI case of LLMs being used to evaluate and treat unusual/rare cancers, predicting the approach will become far more common as understanding of somatic variation expands the very category of rare cancers.
More from Research
- LeanGraphSearch mines Mathlib dependency graphs, lifting proof success to 81% — kaiwei_chang · 2026-10-17
- Perplexity decider v1.2 lands #3 on Decision Index as longer training erodes backbone skills — antoine_chaffin · 2026-10-17
- Perplexity traces decider v1.2 regressions to longer training, mitigates via model souping — antoine_chaffin · 2026-10-17
- Packing multiple questions into one forward pass saves compute but adds instability — antoine_chaffin · 2026-10-17
- pplx-decider packs multiple questions per state into one bidirectional forward pass — antoine_chaffin · 2026-10-17
- Dual-mask fine-tuning recovers cacheability with only -0.4 DI vs full bidirectional — antoine_chaffin · 2026-10-17